Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer

Clinical trial NCT06391034 · RECRUITING

Trial details

NCT number: NCT06391034
Sponsor: Robert Bok, MD, PhD
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2024-09-24
Primary completion: 2028-12-31
Enrollment: 161

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.